The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A three-dimensional human neural cell culture model of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beading or blebbing in neurites is a marker of dystrophic neurites in the AD brain (3, 42, 43).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, tau protein becomes hyperphosphorylated, resulting in tau dissociating from microtubules and forming insoluble tau aggregates in the neurites and cell bodies (3, 37).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Choi et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modeling these pathological hallmarks has largely relied on transgenic cellular and animal models harboring genetic mutations linked to ADAD (3–5).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“As for human neurons, previous studies focused on overexpressing mutant APP and Presenilin in REN stem cells grown in a 3D culture (3), which differs from patient-specific LOAD model that relies on the endogenous recapitulation of AD-associated phenotypes as provided in this study.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
In the citing paper
“one study revealed that familial AD (FAD) mutations in β-amyloid precursor protein and presenilin 1 induced robust extracellular deposition of amyloid-β in a human neural stem-cell-derived 3D culture system85.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“the 3D-differentiated neuronal cells expressing FAD mutations exhibited aggregates of phosphorylated tau as well as filamentous tau.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“A 3D in vitro culture system consisting of human neurons differentiated from induced pluripotent stem cells overexpressing human APP containing FAD mutations generates robust Aβ42 production and amyloid deposition. Importantly, this model also develops elevated phospho-tau levels and fibrillary tau aggregates, suggesting that elevated Aβ levels alone are sufficient to drive tau pathology in human”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Choi et al., 2014
In the citing paper
“It was recently shown that development of a 3D culture of human neural stem cells transfected with APPK670N/M671L/V717I and PS1ΔE9 in Matrigel scaffolding resulted in the extracellular aggregation of Aβ into plaques and the intracellular aggregation of tau in dystrophic neurites and the cell soma [23, 77].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Cohen, R. M., Rezai-Zadeh, K. P., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I. E., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 555
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Flagged first, then by citations
Research works printed but not linked: 1
- Higuchi, M., Trojanowski, J. Q. & Lee, V. M.-Y. Tau protein and tauopathy. Neuropsychopharmacology: The Fifth Generation of Progress (eds Davis, K. L., Charney, D., Coyle, J. T. & Nemeroff, C. ) 1339–1354 (Lippincott, Williams & Wilkins, 2002)
Cited by
Sorted by citations
Items 601–700 of 998
Organotypic Brain Slices of ADULT Transgenic Mice: A Tool to Study Alzheimer’s Disease
Humpel, C. (2018) · Current Alzheimer Research · doi:10.2174/1567205016666181212153138 · Cited by 18
Baden, P., Yu, C., & Deleidi, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.023 · Cited by 17
Generating ventral spinal organoids from human induced pluripotent stem cells
Hor, J., & Ng, S. (2020) · Methods in cell biology · doi:10.1016/bs.mcb.2020.03.010 · Cited by 18
Microphysiological Systems for Neurodegenerative Diseases in Central Nervous System
Bae, M., Yi, H., Jang, J., & Cho, D. (2020) · Micromachines · doi:10.3390/mi11090855 · Cited by 19
Bie, N., Li, J., Li, C., Lian, R., Qin, L., & Wang, C. (2021) · Food & Function · doi:10.1039/d1fo01922h · Cited by 18
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Boder, E. J., & Banerjee, I. A. (2021) · Bioengineering · doi:10.3390/bioengineering8120211 · Cited by 18
Live imaging of microtubule dynamics in organotypic hippocampal slice cultures
Schätzle, P., Kapitein, L. C., & Hoogenraad, C. C. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.06.006 · Cited by 16
Novel advancements in three-dimensional neural tissue engineering and regenerative medicine
McMurtrey, R. J. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.153674 · Cited by 18
Modeling Alzheimer’s disease brains in vitro
Henstridge, C. M., & Spires‐Jones, T. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0177-2 · Cited by 19
Tripathi, S., Ansari, A. A., Singh, M., Dash, M., Kumar, P., Singh, H., Panda, B., Nukavarapu, S. P., Camci‐Unal, G., Li, B., et al. (2025) · Materials Horizons · doi:10.1039/d5mh00501a · Cited by 20
Lai, G., Wu, H., Yang, K., Hu, K., Zhao, W., Chen, X., Li, J., Haifeng, W., Lv, Z., Xie, G., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s525960 · Cited by 19
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17
Martinelli, I., Tayebati, S. K., Tomassoni, D., Nittari, G., Roy, P., & Amenta, F. (2022) · Cells · doi:10.3390/cells11071120 · Cited by 17
Engineering Nanointerfaces of Au25 Clusters for Chaperone-Mediated Peptide Amyloidosis
Gao, G., Liu, X., Gu, Z., Mu, Q., Zhu, G., Zhang, T., Zhang, C., Zhou, L. P., Shen, L., & Sun, T. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00149 · Cited by 17
Self-citationModelling Alzheimer's disease using human brain organoids: current progress and challenges
Yanakiev, M., Soper, O., Berg, D. A., & Kang, E. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.40 · Cited by 17
Wang, Z., Huang, C., Liu, H., Shi, Z., Han, X., Li, S., Huang, J. S., Wang, Z., Yan, Y., & Chen, Z. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113202 · Cited by 17
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Carraro, C., Montgomery, J. V., Klimmt, J., Paquet, D., Schultze, J. L., & Beyer, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1414886 · Cited by 16
Large-scale patterning of single cells and cell clusters in hydrogels
Gong, X., & Mills, K. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-21989-4 · Cited by 18
Hawkins, K., & Duchen, M. R. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i5.236 · Cited by 18
Zhang, S., Xiao, T., Yu, Y., Qiao, Y., Xu, Z., Geng, J., Liang, Y., Mei, Y., Dong, Q., Wang, B., et al. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2906 · Cited by 17
Tezel, G., Timur, S. S., Bozkurt, İ., Türkoğlu, Ö. F., Eroğlu, İ., Nemutlu, E., Öner, L., & Eroğlu, H. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00511 · Cited by 17
Ko, K. R., Tam, N. W., Teixeira, A. G., & Frampton, J. P. (2019) · Biotechnology Progress · doi:10.1002/btpr.2942 · Cited by 17
Nontraditional systems in aging research: an update
Mikuła‐Pietrasik, J., Pakuła, M., Markowska, M., Uruski, P., Szczepaniak‐Chicheł, L., Tykarski, A., & Książek, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03658-w · Cited by 15
Kang, M. S., Shin, M., Ottoy, J., Aliaga, A., Mathotaarachchi, S. S., Quispialaya, K. M., Pascoal, T. A., Collins, D. L., Chakravarty, M. M., Mathieu, A. P., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211035625 · Cited by 17
Li, Z.-F., Cui, L., Jin, M.-M., Hu, D., Hou, X.-G., Liu, S.-S., Zhang, X., & Zhu, J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049125 · Cited by 18
Water-insoluble, nanocrystalline, and hydrogel fibrillar scaffolds for biomedical applications
Kang, D., Kim, D., Wang, S., Song, D., & Yoon, M. (2018) · Polymer Journal · doi:10.1038/s41428-018-0053-7 · Cited by 17
Self-citationEngineering microsystems to recapitulate brain physiology on a chip
Ndyabawe, K., & Kisaalita, W. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.008 · Cited by 17
Joshi, P., Kang, S. Y., Yu, K.-N., Kothapalli, C. R., & Lee, M. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104765 · Cited by 17
Porterfield, V. M., Khan, S. S., Foff, E. P., Köseoğlu, M. M., Blanco, I. K., Jayaraman, S., Lien, E. L., McConnell, M. J., Bloom, G. S., Lazo, J. S., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.011 · Cited by 18
Molecular Diversity Among Adult Human Hippocampal and Entorhinal CellsPreprint
Franjic, D., Choi, J., Škarica, M., Xu, C., Li, Q., Ma, S., Tebbenkamp, A. T. N., Santpere, G., Arellano, J. I., Gudelj, I., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.31.889139 · Cited by 16
Zhou, S., Ochałek, A., Szczęsna, K., Avci, H. X., Kobolák, J., Varga, E., Rasmussen, M. A., Holst, B., Cirera, S., Hyttel, P., et al. (2016) · Differentiation · doi:10.1016/j.diff.2016.06.002 · Cited by 16
Bhargava, A., Sandoval-Castellanos, A. M., Shah, S. S., & Ning, K. (2022) · Interface Focus · doi:10.1098/rsfs.2022.0040 · Cited by 15
Efficient generation of brain organoids using magnetized gold nanoparticles
Kim, H., Lee, Y., Kwon, Y., & Kim, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-48655-8 · Cited by 17
Human stem cell transplantation models of Alzheimer’s disease
Ifediora, N., Canoll, P., & Hargus, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1354164 · Cited by 18
Relationship between exosomes and cancer: formation, diagnosis, and treatment
Huang, C., Li, J., Xie, Z., Hu, X., & Huang, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95763 · Cited by 19
The use of human neurons for novel drug discovery in dementia research
Vargas‐Caballero, M., Willaime‐Morawek, S., Gómez‐Nicola, D., Perry, V. H., Bulters, D. O., & Mudher, A. K. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1154528 · Cited by 15
Han, F., Liu, C., Huang, J., Chen, J., Wei, C., Geng, X., Liu, Y., Han, D., & Li, M. (2019) · Brain Science Advances · doi:10.1177/2096595819896178 · Cited by 16
Advanced Materials to Enhance Central Nervous System Tissue Modeling and Cell Therapy
Muckom, R. J., Sampayo, R. G., Johnson, H. J., & Schaffer, D. V. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002931 · Cited by 16
Vignon, A., Salvador-Prince, L., Lehmann, S., Perrier, V., & Torrent, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168769 · Cited by 17
Grekhnev, D. A., Kaznacheyeva, E. V., & Vigont, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020624 · Cited by 16
Human brain organoid code of conduct
Hoppe, M., Habib, A., Desai, R., Edwards, L., Kodavali, C. V., Sherry, N. S., & Zinn, P. O. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1143298 · Cited by 16
Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds
Vorberg, I. M., & Chiesa, R. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.002 · Cited by 16
Immunity in Alzheimer’s disease: From mechanisms to therapies
Chen, X., Holtzman, D. M., & Colonna, M. (2026) · Immunity · doi:10.1016/j.immuni.2026.02.004 · Cited by 18
Ma, S., Cong, Z., Chen, H., Han, W., Cao, L., Liu, C., Yang, F., & Liao, Y. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106003 · Cited by 15
Self-citationShao, X., Liu, Z., Mao, S., & Han, L. G. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200760 · Cited by 14
Wang, J., Wang, A., Tian, K., Hua, X., Zhang, B., Zheng, Y., Kong, X., Li, W., Xu, L., Wang, J., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00421-2 · Cited by 15
Intracellular tau fragment droplets serve as seeds for tau fibrils
Soeda, Y., Yoshimura, H., Bannai, H., Koike, R., Shiiba, I., & Takashima, A. (2024) · Structure · doi:10.1016/j.str.2024.06.018 · Cited by 15
James, E. C., Tomaskovic‐Crook, E., & Crook, J. M. (2024) · Advanced Science · doi:10.1002/advs.202310010 · Cited by 15
Preventing the Spread of Alzheimer’s Disease Neuropathology: A Role for Calcilytics?
Chiarini, A., Gardenal, E., Whitfield, J., Chakravarthy, B., Armato, U., & Prà, I. D. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201016666150505123813 · Cited by 14
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Liu, X., Sun, Q., Wang, Q., Hu, C., Chen, X., Li, H., Czajkowsky, D. M., & Shao, Z. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.06.017 · Cited by 18
What is the gold standard model for Alzheimer’s disease drug discovery and development?
Cacabelos, R., Carrera, I., Martínez-Iglesias, O. A., Cacabelos, N., & Naidoo, V. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1960502 · Cited by 15
Engineered Aging Cardiac Tissue Chip Model for Studying Cardiovascular Disease
Budhathoki, S., Graham, C., Sethu, P., & Kannappan, R. (2021) · Cells Tissues Organs · doi:10.1159/000516954 · Cited by 15
Simão, D. F., Gomes, C. M., Alves, P. M., & Brito, C. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107883 · Cited by 15
Zhu, X., Ma, T., Liu, L., & Dai, W.-Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332160 · Cited by 16
Organoids for modeling prion diseases
Walters, R. O., & Haigh, C. L. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03589-x · Cited by 15
Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 14
Rodent Models for Alzheimer’s Disease in Drug Discovery
Barrett, J. E., & McGonigle, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00012-x · Cited by 15
Modeling tau pathology in human stem cell derived neurons
Wray, S. (2017) · Brain Pathology · doi:10.1111/bpa.12521 · Cited by 14
Liang, F., Wan, Y., Schaak, D., Ward, J. F., Shen, X., Tanzi, R. E., Zhang, C. M., & Quan, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-05619-z · Cited by 16
Self-citationSowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease
Bell, B. J., Malvankar, M. M., Tallon, C., & Slusher, B. S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00531 · Cited by 15
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation
Nguyen, H. N. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2213-1_10 · Cited by 17
Ma, C., Su, J., Sun, Y., Feng, Y., Shen, N., Li, B., Liang, Y., Yang, X., Wu, H., Zhang, H., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201912399 · Cited by 14
Self-citationMadl, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.106825 · Cited by 16
Adapting tissue-engineered in vitro CNS models for high-throughput study of neurodegeneration
O’Rourke, C., Lee-Reeves, C., Drake, R. A. L., Cameron, G. W. W., Loughlin, J., & Phillips, J. B. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417697920 · Cited by 14
Fabrication of thin‐layer matrigel‐based constructs for three‐dimensional cell culture
Ko, K. R., Tsai, M., & Frampton, J. P. (2018) · Biotechnology Progress · doi:10.1002/btpr.2733 · Cited by 14
Wuli, W., Tsai, S., Chiou, T., & Harn, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041327 · Cited by 16
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer’s Disease
Shoup, T. M., Griciuc, A., Normandin, M. D., Quinti, L., Walsh, L. V., Dhaynaut, M., Moon, S., Guehl, N. J., Brugarolas, P., Elmaleh, D. R., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201419 · Cited by 14
Self-citationMitochondria-Microbiota Interaction in Neurodegeneration
Krämer, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.776936 · Cited by 14
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220031 · Cited by 15
Hu, S., Wang, R., Cui, W., Mak, S., Li, G., Yuanjia, H., Lee, M., Pang, Y., & Han, Y. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12472 · Cited by 14
Cells and Organs on Chip—A Revolutionary Platform for Biomedicine
Joshi, P. N. (2016) · InTech eBooks · doi:10.5772/64102 · Cited by 15
Simplified Murine 3D Neuronal Cultures for Investigating Neuronal Activity and Neurodegeneration
Collins, S. J., & Haigh, C. L. (2016) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-016-0768-z · Cited by 14
Singh, S., Srivastava, A., Srivastava, P., Dhuriya, Y. K., Pandey, A., Kumar, D., & Rajpurohit, C. S. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00072 · Cited by 14
Joshi, P., Yu, K.-N., Kang, S. Y., Kwon, S., Kwon, P. S., Dordick, J. S., Kothapalli, C. R., & Lee, M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.034 · Cited by 14
Assessing drug response in engineered brain microenvironments
Tate, K. M., & Munson, J. M. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.027 · Cited by 14
Cost-Effective Cosmetic-Grade Hyaluronan Hydrogels for ReNcell VM Human Neural Stem Cell Culture
Ma, W., & Suh, W. H. (2019) · Biomolecules · doi:10.3390/biom9100515 · Cited by 14
Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
Lee, D., Choi, Y. H., Seo, J., Kim, J. K., & Lee, S. B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101069 · Cited by 14
Self-citationChen, S.-D., Li, H., Cui, M., Dong, Q., & Yu, J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767579 · Cited by 15
Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
Beghini, D. G., Horita, S. I. M., Cascabulho, C. M., Alves, L. A., & Henriques‐Pons, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155467 · Cited by 22
Potential Role for Herpesviruses in Alzheimer’s Disease
Duggan, M. R., Torkzaban, B., Ahooyi, T. M., & Khalili, K. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200814 · Cited by 13
Cusulin, C., Wells, I., Badillo, S., Duran-Pacheco, G. C., Baumann, K., & Patsch, C. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103392 · Cited by 13
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
Wendt, S., Lin, A. J., Ebert, S. N., Brennan, D. J., Cai, W., Bai, Y., Kong, D. Y., Sorrentino, S., Groten, C. J., Lee, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03433-3 · Cited by 13
Wang, H., Qiao, Y., Lu, H., Bo, X., Chen, F., Pu, N., Zhou, Y., & Cheng, Q. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107224 · Cited by 13
Engineered Human Induced Pluripotent Cells Enable Genetic Code Expansion in Brain Organoids
van Husen, L. S., Katsori, A., Meineke, B., Tjernberg, L. O., Schedin‐Weiss, S., & Elsässer, S. J. (2021) · ChemBioChem · doi:10.1002/cbic.202100399 · Cited by 13
Multi-target regulatory mechanism of Yang Xin Tang − a traditional Chinese medicine against dementia
Lo, T. Y., Chan, A. S. L., Cheung, S. T., Yung, L. Y., Leung, M. M. H., & Wong, Y. H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00813-w · Cited by 16
FGFR3 drives Aβ-induced tau uptake
Kim, D. K., Suh, K. Y., Park, J., Lee, S., Han, J., Chang, S., Kim, Y., & Mook‐Jung, I. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01274-3 · Cited by 14
Self-citationBrain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 14
Parrotta, E. I., Lucchino, V., Zannino, C., Valente, D., Scalise, S., Bressan, D., Benedetto, G. L., Iazzetta, M. R., Talarico, M., Gagliardi, M., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27172 · Cited by 14
Timofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
A Novel Cell Penetrating Peptide for the Differentiation of Human Neural Stem Cells
Ma, W., Jin, G., Gehret, P. M., Chada, N. C., & Suh, W. H. (2018) · Biomolecules · doi:10.3390/biom8030048 · Cited by 13
Snow, A. D., Cummings, J. A., Tanzi, R. E., & Lake, T. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-79275-1 · Cited by 14
Self-citationGutova, M., B, J. P. C. A., Adhikarla, V., Tsaturyan, L., Barish, M. E., Rockne, R. C., Moschonas, E. H., Bondi, C. O., & Kline, A. E. (2021) · Stem Cells International · doi:10.1155/2021/5549381 · Cited by 14
Biomaterials-based strategies for in vitro neural models
Özgün, A., Lomboni, D. J., Arnott, H. G., Staines, W. A., Woulfe, J., & Variola, F. (2022) · Biomaterials Science · doi:10.1039/d1bm01361k · Cited by 13
Ge, T., & Yuan, Y. (2022) · BioMed Research International · doi:10.1155/2022/8804925 · Cited by 13
RetractedErgin, A. D., Üner, B., Balcı, Ş., Demirbağ, Ç., Benetti, C., & Oltulu, Ç. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.07.020 · Cited by 13
Metadata
- Authors
- Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., & Kim, D. Y.
- Affiliations
- Harvard University (US)
- University of Bonn (DE)
- Boston Children's Hospital (US)
- Whitehead Institute for Biomedical Research (US)
- University of California San Diego (US)
- Corresponding author
- Tanzi, Rudolph E.
- Kim, Doo Yeon
- ORCID
- Venue
- Nature
- Published
- 2014-10-12
- Volume
- 515
- Issue
- 7526
- Pages
- 274-278
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4366007
- OpenAlex
- W2126231259
- Cited by
- 1,195
- References
- 30
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 95 · 2023: 88 · 2022: 112 · 2021: 111 · 2020: 141 · 2019: 109 · 2018: 109 · 2017: 87 · 2016: 97 · 2015: 87 · 2014: 14
- FWCI
- 63.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Massachusetts General Hospital
- Cure Alzheimer's Fund
- University of Edinburgh
- National Institute on Aging (5P01 AG15379, P01AG015379, R21AG031483, RF1AG048080, P50AG005134, R01AG014713, P01AG004953, P30AG062421)
- National Institute of Mental Health (R37MH060009)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
- National Institute of Neurological Disorders and Stroke (P30NS045776, R01NS045860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, familial Alzheimer's disease, amyloid plaques, tauopathy, neurofibrillary tangles, amyloid hypothesis, presenilin 1 mutations, human neural stem cells, 3D cell culture, human neurons, beta-secretase inhibition, gamma-secretase inhibition, tau phosphorylation, drug screening model
- MeSH terms
- Alzheimer Disease, Cell Differentiation, Drug Evaluation, Preclinical, Extracellular Space, Humans, Microtubule-Associated Proteins, Models, Biological, Phosphorylation, Reproducibility of Results, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Culture Techniques, Glycogen Synthase Kinase 3, Presenilin-1, Neural Stem Cells, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
